Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea‐predominant irritable bowel syndrome

View through CrossRef
AbstractBackground  The intestinal microbiota has been implicated in the pathophysiology of irritable bowel syndrome (IBS). Due to the variable resolutions of techniques used to characterize the intestinal microbiota, and the heterogeneity of IBS, the defined alterations of the IBS intestinal microbiota are inconsistent. We analyzed the composition of the intestinal microbiota in a defined subgroup of IBS patients (diarrhea‐predominant IBS, D‐IBS) using a technique that provides the deepest characterization available for complex microbial communities.Methods  Fecal DNA was isolated from 23 D‐IBS patients and 23 healthy controls (HC). Variable regions V1–V3 and V6 of the 16S rRNA gene were amplified from all samples. PCR products were sequenced using 454 high throughput sequencing. The composition, diversity and richness of microbial communities were determined and compared between D‐IBS and HC using the quantitative insights into microbial ecology pipeline.Key Results  The contribution of bacterial groups to the composition of the intestinal microbiota differed between D‐IBS and HC. D‐IBS patients had significantly higher levels of Enterobacteriaceae (P = 0.03), and lower levels of Fecalibacterium genera (P = 0.04) compared to HC. β‐Diversity values demonstrated significantly lower levels of UniFrac distances in HC compared to D‐IBS patients. The richness of 16S rRNA sequences was significantly decreased in D‐IBS patients (P < 0.04).Conclusions & Inferences  Our 16S rRNA sequence data demonstrates a community‐level dysbiosis in D‐IBS. The altered composition of the intestinal microbiota in D‐IBS is associated with significant increases in detrimental and decreases in beneficial bacterial groups, and a reduction in microbial richness.
Title: Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea‐predominant irritable bowel syndrome
Description:
AbstractBackground  The intestinal microbiota has been implicated in the pathophysiology of irritable bowel syndrome (IBS).
Due to the variable resolutions of techniques used to characterize the intestinal microbiota, and the heterogeneity of IBS, the defined alterations of the IBS intestinal microbiota are inconsistent.
We analyzed the composition of the intestinal microbiota in a defined subgroup of IBS patients (diarrhea‐predominant IBS, D‐IBS) using a technique that provides the deepest characterization available for complex microbial communities.
Methods  Fecal DNA was isolated from 23 D‐IBS patients and 23 healthy controls (HC).
Variable regions V1–V3 and V6 of the 16S rRNA gene were amplified from all samples.
PCR products were sequenced using 454 high throughput sequencing.
The composition, diversity and richness of microbial communities were determined and compared between D‐IBS and HC using the quantitative insights into microbial ecology pipeline.
Key Results  The contribution of bacterial groups to the composition of the intestinal microbiota differed between D‐IBS and HC.
D‐IBS patients had significantly higher levels of Enterobacteriaceae (P = 0.
03), and lower levels of Fecalibacterium genera (P = 0.
04) compared to HC.
β‐Diversity values demonstrated significantly lower levels of UniFrac distances in HC compared to D‐IBS patients.
The richness of 16S rRNA sequences was significantly decreased in D‐IBS patients (P < 0.
04).
Conclusions & Inferences  Our 16S rRNA sequence data demonstrates a community‐level dysbiosis in D‐IBS.
The altered composition of the intestinal microbiota in D‐IBS is associated with significant increases in detrimental and decreases in beneficial bacterial groups, and a reduction in microbial richness.

Related Results

Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine
Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine
CONTEXT: Recent studies support the hypothesis that postinfectious irritable bowel syndrome and some irritable bowel syndrome patients display persistent signs of minor mucosal inf...
Complementary and alternative medicine in patients with irritable bowel syndrome: A Pilot Study
Complementary and alternative medicine in patients with irritable bowel syndrome: A Pilot Study
Irritable bowel syndrome (IBS) is considered a chronic functional bowel disorder that causes abdominal pain, bloating, alternating diarrhea and constipation without affecting struc...
Abstracts for the 6th European Symposium on Gastrointestinal Motility 19–21 NOVEMBER 1992 HOTEL MELIA BARCELONA, BARCELONA, SPAIN
Abstracts for the 6th European Symposium on Gastrointestinal Motility 19–21 NOVEMBER 1992 HOTEL MELIA BARCELONA, BARCELONA, SPAIN
MOTOR RESPONSES OF HUMAN ILEUM TO TACHYKININS IN VITRO: EXISTENCE OF NK2 RECEPTORS AND RECEPTORS SPECIFIC FOR NEUROPEPTIDE GAMMA.INNERVATION OF THE MUSCULARIS MUCOSAE OF HUMAN COLO...
Comparison of the intestinal microbiota composition and function in healthy and diseased Yunlong Grouper
Comparison of the intestinal microbiota composition and function in healthy and diseased Yunlong Grouper
AbstractMaintaining stabilization of the intestinal microbiota is important in preventing bacterial diseases in cultured fish. At present, there have been no reports on the composi...
Gut-directed guided affective imagery as an adjunct to dietary modification in irritable bowel syndrome
Gut-directed guided affective imagery as an adjunct to dietary modification in irritable bowel syndrome
This work aimed to study the effect of guided affective imagery on the irritable bowel syndrome. A total of 15 irritable bowel syndrome patients received guided affective imagery a...
The Microbiota and Microbiome in COVID-19 in Adults and Children and Potential Therapeutic Interventions: A Review
The Microbiota and Microbiome in COVID-19 in Adults and Children and Potential Therapeutic Interventions: A Review
The work presented is a comprehensive review of the role of the human microbiota in the context of the COVID-19 pandemic. A diverse microbial community heavily colonizes the human ...

Back to Top